Stockreport

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering [Yahoo! Finance]

Artiva Biotherapeutics, Inc.  (ARTV) 
PDF to develop effective, safe and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced the pricing of its upsized initia [Read more]